In vitro evaluation of acyloxyalkyl esters as dermal prodrugs of ketoprofen and naproxen. 1998

J Rautio, and H Taipale, and J Gynther, and J Vepsalainen, and T Nevalainen, and T Jarvinen
Department of Pharmaceutical Chemistry, University of Kuopio, Finland. Jarkko.Rautio@uku.fi

A series of acyloxyalkyl esters of ketoprofen and naproxen were synthesized and investigated as topical prodrugs with the aim of improving the dermal delivery of the drugs. In addition, some hydroxyalkyl esters of ketoprofen and naproxen were synthesized as possible intermediates of acyloxyalkyl prodrugs. All of the prodrugs were more lipophilic than their parent molecules, as evaluated by drug partitioning between 1-octanol and phosphate buffer at pH 7.4 (log Papp). However, their solubilities in aqueous solutions decreased markedly compared with the parent molecules. The prodrugs were stable toward chemical hydrolysis in aqueous solutions (pH 7.4), but were hydrolyzed to the parent drug both in 80% human serum and in human skin homogenate, with half-lives ranging from 4 to 137 min and from 13 to 403 min, respectively. The abilities of the selected naproxen acyloxyalkyl prodrugs to deliver naproxen through excised human skin were evaluated. Generally, the prodrugs showed similar dermal delivery as the parent drug through cadaver skin. In the present series of lipophilic prodrugs of naproxen, the prodrug with the highest aqueous solubility was the most effective prodrug to deliver naproxen through the skin.

UI MeSH Term Description Entries
D007660 Ketoprofen An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis. Benzoylhydratropic Acid,19,583 RP,2-(3-Benzoylphenyl)propionic Acid,Alrheumat,Alrheumum,Orudis,Profenid,RP-19583,RP 19583,RP, 19,583,RP19583
D009288 Naproxen An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout. Aleve,Anaprox,Methoxypropiocin,Naprosin,Naprosyn,Naproxen Sodium,Proxen,Sodium Naproxenate,Synflex,Naproxenate, Sodium,Sodium, Naproxen
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000215 Acylation The addition of an organic acid radical into a molecule.
D000478 Alkylation The covalent bonding of an alkyl group to an organic compound. It can occur by a simple addition reaction or by substitution of another functional group. Alkylations
D012879 Skin Physiological Phenomena The functions of the skin in the human and animal body. It includes the pigmentation of the skin. Skin Physiological Processes,Skin Physiology,Physiology, Skin,Skin Physiological Concepts,Skin Physiological Phenomenon,Skin Physiological Process,Concept, Skin Physiological,Concepts, Skin Physiological,Phenomena, Skin Physiological,Phenomenas, Skin Physiological,Phenomenon, Skin Physiological,Phenomenons, Skin Physiological,Physiological Concept, Skin,Physiological Concepts, Skin,Physiological Phenomena, Skin,Physiological Phenomenas, Skin,Physiological Phenomenon, Skin,Physiological Phenomenons, Skin,Process, Skin Physiological,Processes, Skin Physiological,Skin Physiological Concept,Skin Physiological Phenomenas,Skin Physiological Phenomenons
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities

Related Publications

J Rautio, and H Taipale, and J Gynther, and J Vepsalainen, and T Nevalainen, and T Jarvinen
September 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
J Rautio, and H Taipale, and J Gynther, and J Vepsalainen, and T Nevalainen, and T Jarvinen
February 2003, Drug development and industrial pharmacy,
J Rautio, and H Taipale, and J Gynther, and J Vepsalainen, and T Nevalainen, and T Jarvinen
December 1999, Journal of medicinal chemistry,
J Rautio, and H Taipale, and J Gynther, and J Vepsalainen, and T Nevalainen, and T Jarvinen
August 2002, Die Pharmazie,
J Rautio, and H Taipale, and J Gynther, and J Vepsalainen, and T Nevalainen, and T Jarvinen
March 2006, The Journal of pharmacy and pharmacology,
J Rautio, and H Taipale, and J Gynther, and J Vepsalainen, and T Nevalainen, and T Jarvinen
March 2002, Bioorganic & medicinal chemistry,
J Rautio, and H Taipale, and J Gynther, and J Vepsalainen, and T Nevalainen, and T Jarvinen
May 2008, International journal of pharmaceutics,
J Rautio, and H Taipale, and J Gynther, and J Vepsalainen, and T Nevalainen, and T Jarvinen
January 2002, Journal of biomaterials science. Polymer edition,
J Rautio, and H Taipale, and J Gynther, and J Vepsalainen, and T Nevalainen, and T Jarvinen
May 2007, International journal of pharmaceutics,
J Rautio, and H Taipale, and J Gynther, and J Vepsalainen, and T Nevalainen, and T Jarvinen
August 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Copied contents to your clipboard!